Gunther Birznieks - Aug 26, 2022 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role
SVP, Business Development
Signature
/s/ Gunther Birznieks
Stock symbol
VNDA
Transactions as of
Aug 26, 2022
Transactions value $
$3,900
Form type
4
Date filed
8/29/2022, 05:02 PM
Previous filing
Mar 2, 2022
Next filing
Feb 21, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNDA Common Stock Options Exercise $3.9K +1.25K +0.66% $3.12 190K Aug 26, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VNDA Employee Stock Option (Right to Buy) Options Exercise $0 -1.25K -100% $0.00* 0 Aug 26, 2022 Common Stock 1.25K $3.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested in 48 equal monthly installments beginning on December 7, 2012.